Yahoo! Finance: VPHM News

Coverage initiated on ViroPharma by Jefferies & Co (Briefing.com)

Thu, 17 Dec 2009 10:39:56 Etc/GMT

I Love This Industry (at Motley Fool)

Thu, 3 Dec 2009 21:40:14 Etc/GMT

Dyax: FDA Approval Boosts Prospects (at Seeking Alpha)

Thu, 3 Dec 2009 17:11:42 Etc/GMT

UPDATE - Dyax shrs soar after FDA approves genetic-disorder drug (at Reuters)

Wed, 2 Dec 2009 15:52:18 Etc/GMT

The FDA Moves the Goalposts (at Motley Fool)

Mon, 30 Nov 2009 19:14:47 Etc/GMT

Biotech Bargains for Your Portfolio (at Motley Fool)

Fri, 27 Nov 2009 15:58:57 Etc/GMT

7 Highly Rated Stocks on Sale (at Motley Fool)

Wed, 4 Nov 2009 17:43:10 Etc/GMT

VIROPHARMA INC Financials (EDGAR Online Financials)

Tue, 3 Nov 2009 14:04:56 Etc/GMT

ViroPharma to Present at Three November Healthcare Conferences (PR Newswire)

Thu, 29 Oct 2009 20:13:00 Etc/GMT

ViroPharma Incorporated today announced that the company will be presenting at several upcoming healthcare investment conferences.

Drink In These 5 Top Stocks (at Motley Fool)

Thu, 29 Oct 2009 19:03:46 Etc/GMT

ViroPharma Incorporated Q3 2009 Earnings Call Transcript (at Seeking Alpha)

Wed, 28 Oct 2009 18:52:08 Etc/GMT

ViroPharma Earnings Call scheduled for 9:00 am ET today (CCBN)

Wed, 28 Oct 2009 13:00:00 Etc/GMT

VIROPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (EDGAR Online)

Wed, 28 Oct 2009 12:39:25 Etc/GMT

ViroPharma Incorporated Reports Third Quarter 2009 Financial Results (PR Newswire)

Wed, 28 Oct 2009 11:30:00 Etc/GMT

ViroPharma Incorporated reported today its financial results for the third quarter ended September 30, 2009.

Q3 2009 ViroPharma Earnings Release - Before Market Open (CCBN)

Wed, 28 Oct 2009 11:07:52 Etc/GMT

Dream Stocks for Contrarian Investors (at Motley Fool)

Tue, 27 Oct 2009 20:08:13 Etc/GMT

Biotech Mergers And Acquisitions Will Accelerate According To Wedbush Morgan Expert Analyst As More Expensive Phase III Trials Force Small Biotech Companies Into Large Pharma Distribution And Finance Organizations (Wall Street Transcript)

Tue, 20 Oct 2009 14:21:00 Etc/GMT

67 WALL STREET, New York - October 20, 2009 - The Wall Street Transcript has just published its Biotechnology Report offering a timely review of the sector to serious investors and industry executives. This 70 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

ViroPharma to Release 2009 Third Quarter Financial Results on October 28, 2009 (PR Newswire)

Thu, 15 Oct 2009 20:00:00 Etc/GMT

Intel, American Tower: Ratings Changes (at TheStreet.com)

Thu, 15 Oct 2009 09:00:00 Etc/GMT

American Tower, SAIC: Ratings Changes (at TheStreet.com)

Thu, 15 Oct 2009 09:00:00 Etc/GMT